TMO|EPS $5.44 vs $5.28 est (+3.0%)|Rev $11.01B|Net Income $1.65BThermo Fisher Scientific Inc. (TMO) reported Q1 2026 adjusted earnings of $5.44 per share, beating the $5.28 consensus estimate (beat by 3.0%). Revenue totaled $11.01B for the quarter. Revenue was up 6.0% year-over-year.
Thermo Fisher Scientific Inc. is a Diagnostics & Research company. Organic revenue growth was +1.0% for the quarter. Laboratory Products and Biopharma Services generated $6.04B in revenue for the quarter. The company earned $2.03B in adjusted net income.
Wall Street consensus stands at 20 buy, 4 hold, 0 sell.
A detailed analysis of Thermo Fisher Scientific Inc.’s quarter follows shortly on AlphaStreet.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.